NCT05624814

Brief Summary

Spinal cord stimulation (SCS) is a therapeutic option for patients with chronic low back pain (CLBP) syndrome, when pharmacological, psychological, physical and occupational therapies or surgery fail to reduce symptoms. CLBP is a common disease with several negative consequences on the quality of life, work and activity ability and increased costs to the health-care system. We have therefore designed this observational study to assess global cognitive functioning in three different groups of patients: patients with chronic pain undergoing intervention (experimental group), patients with chronic pain following traditional therapies (comparison group) and healthy participants matched for age and schooling (healthy subjects). A neuropsychological assessment battery designed to assess global cognitive functioning, behavioral symptomatology, metacognition, quality of life, interoception, pain perception, self-efficacy, and coping styles will be conducted.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 22, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

November 22, 2022

Status Verified

November 1, 2022

Enrollment Period

12 months

First QC Date

November 14, 2022

Last Update Submit

November 14, 2022

Conditions

Keywords

Spinal Cord StimulationPsychological DisabilityCognitive ImpairmentQuality of LifeMetacognitionPain and Disability

Outcome Measures

Primary Outcomes (2)

  • Global Cognitive Functioning - Montreal Cognitive Assessment

    Montreal Cognitive Assessment provides screening of global cognitive functioning; it is composed of 12 subtasks exploring: memory; visuospatial abilities assessed by a clock-drawing task and by copying of a cube; executive functions assessed by means of a brief version of the Trail Making B task, a phonemic fluency task, and a two-item verbal abstraction task; attention, concentration and working memory assessed by means of a sustained attention task (target detection using tapping), a serial subtraction task, and forward and backward span tasks for digits; language assessed by a naming task with low-familiarity animals, repetition of two syntactically complex sentences and the above-mentioned phonemic fluency task; temporal and spatial orientation.

    At patient's inclusion

  • Global Cognitive Functioning - Raven's Colored Progressive Matrices Test

    The Raven's Colored Progressive Matrices Test assesses abstract reasoning abilities with nonverbal material. The test consists of 36 matrices, grouped into 3 sets of increasing difficulty. Each matrix has a missing piece that the subject must choose from six alternatives available. The total score ranges from 0 to 36 and is obtained by summing the number of correct answers.

    At patient's inclusion

Secondary Outcomes (16)

  • Metacognition - Memory Assessment Clinics-Questionnaire

    At patient's inclusion

  • Metacognition - Multifactorial Memory Questionnaire

    At patient's inclusion

  • Metacognition - Adult Executive Functioning Inventory

    At patient's inclusion

  • Quality of life

    At patient's inclusion

  • Behavioral Symptomatology - Beck Depression Inventory

    At patient's inclusion

  • +11 more secondary outcomes

Study Arms (3)

Experimental group

Patients with chronic pain which failed standard therapies and with an implanted Spinal Cord Stimulator

Device: Spinal Cord Stimulation

Comparison group

Patients with chronic pain following traditional therapies, i.e. pharmacological, psychological, physical and occupational therapies or surgery.

Other: Standard therapies

Control group

Healthy volunteers matched for age and schooling to those included in the experimental group

Interventions

Spinal Cord Stimulation consists of the transcutaneous or surgical implantation of different types of electrodes in the epidural space; electrodes are then connected to an Implanted Pulse Generator that generates stimulating currents.

Experimental group

Standard therapies for chronic low back pain are pharmacological, psychological, physical and occupational therapies or surgery.

Comparison group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

60 consecutive patients (20 per cohort) will be enrolled if they meet the inclusion criteria and no exclusion criteria as per cohort.

You may qualify if:

  • age greater than 18 years
  • presence of chronic pain treated with spinal cord stimulation (Experimental Group)
  • presence of chronic pain receiving standard therapies (Comparison Group)
  • healthy participants matched for age and schooling (Control Group).

You may not qualify if:

  • consent denied

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Mater Domini

Catanzaro, Italy

Location

MeSH Terms

Conditions

Cognitive DysfunctionPain

Interventions

Spinal Cord Stimulation

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Federico Longhini, MD

    Magna Graecia University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federico Longhini, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Intensive Care and Anesthesia Department

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 22, 2022

Study Start

January 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

November 22, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

Anonymous data will be shared with al researchers after publication, on reasonable scientific request to the Principal Investigator

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
After study publication
Access Criteria
On reasonable scientific request by email the Principal Investigator

Locations